These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36317631)

  • 21. FOXA1 inhibits prostate cancer neuroendocrine differentiation.
    Kim J; Jin H; Zhao JC; Yang YA; Li Y; Yang X; Dong X; Yu J
    Oncogene; 2017 Jul; 36(28):4072-4080. PubMed ID: 28319070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
    Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
    Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.
    Aparicio A; Tzelepi V; Araujo JC; Guo CC; Liang S; Troncoso P; Logothetis CJ; Navone NM; Maity SN
    Prostate; 2011 Jun; 71(8):846-56. PubMed ID: 21456067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer.
    Evans AJ; Humphrey PA; Belani J; van der Kwast TH; Srigley JR
    Am J Surg Pathol; 2006 Jun; 30(6):684-93. PubMed ID: 16723845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?
    Slovin SF
    Nat Clin Pract Urol; 2006 Mar; 3(3):138-44. PubMed ID: 16528286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy considerations in neuroendocrine prostate cancer: what next?
    Beltran H; Demichelis F
    Endocr Relat Cancer; 2021 Jul; 28(8):T67-T78. PubMed ID: 34111024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate carcinoma with neuroendocrine differentiation: case report and literature review.
    Fernandes RC; Matsushita MM; Mauad T; Nascimento Saldiva PH
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):153-8. PubMed ID: 11781596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
    Tsai HK; Lehrer J; Alshalalfa M; Erho N; Davicioni E; Lotan TL
    BMC Cancer; 2017 Nov; 17(1):759. PubMed ID: 29132337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
    Puca L; Gavyert K; Sailer V; Conteduca V; Dardenne E; Sigouros M; Isse K; Kearney M; Vosoughi A; Fernandez L; Pan H; Motanagh S; Hess J; Donoghue AJ; Sboner A; Wang Y; Dittamore R; Rickman D; Nanus DM; Tagawa ST; Elemento O; Mosquera JM; Saunders L; Beltran H
    Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894499
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Bhagirath D; Yang TL; Tabatabai ZL; Majid S; Dahiya R; Tanaka Y; Saini S
    Clin Cancer Res; 2019 Nov; 25(21):6532-6545. PubMed ID: 31371344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroendocrine differentiation and metastasized to brain stem, intraorbit and base of tongue in prostate cancer during hormonal treatment: a case report].
    Sugi M; Yanishi M; Shimada O; Kawakita S; Murota T; Shikata N
    Hinyokika Kiyo; 2008 May; 54(5):373-6. PubMed ID: 18546865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine and paracrine characteristics of neuroendocrine prostate cancer.
    Arman T; Nelson PS
    Front Endocrinol (Lausanne); 2022; 13():1012005. PubMed ID: 36440195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].
    Campedel L; Kossaï M; Blanc-Durand P; Rouprêt M; Seisen T; Compérat E; Spano JP; Malouf G
    Bull Cancer; 2017 Sep; 104(9):789-799. PubMed ID: 28673439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of neuroendocrine prostate carcinoma: Literature review].
    Yossi S; Brahmi T; Enachescu C; Selmaji I; Lapierre A; Samlali H; Chapet O
    Cancer Radiother; 2016 Jun; 20(4):330-5. PubMed ID: 27340027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms underlying the development of neuroendocrine prostate cancer.
    Liu S; Alabi BR; Yin Q; Stoyanova T
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):57-68. PubMed ID: 35597438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.
    Zhang C; Qian J; Wu Y; Zhu Z; Yu W; Gong Y; Li X; He Z; Zhou L
    Pathol Oncol Res; 2021; 27():1609968. PubMed ID: 34646089
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuroendocrine tumors of the prostate].
    Bours AF; Jorion JL; Donnay M; Ledent G; Van Ruyssevelt C
    Acta Urol Belg; 1993 Sep; 61(3):13-6. PubMed ID: 8256680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
    Alshalalfa M; Liu Y; Wyatt AW; Gibb EA; Tsai HK; Erho N; Lehrer J; Takhar M; Ramnarine VR; Collins CC; Den RB; Schaeffer EM; Davicioni E; Lotan TL; Bismar TA
    Int J Cancer; 2019 Dec; 145(12):3453-3461. PubMed ID: 31125117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
    Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
    Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
    Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
    Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.